Clinical Trials Browser

Terminated × budigalimab × Gynecologic × Clear all

NCT03138408 2019-05-14

SC-004 Alone or With ABBV-181 in Subjects With Epithelial Ovarian, Fallopian Tube, Primary Peritoneal and Endometrial Cancers

Phase 1 Terminated

Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT02539719 2019-01-04

Study of SC-003 Alone and in Combination With ABBV-181 in Subjects With Platinum-Resistant/Refractory Ovarian Cancer

Phase 1 Terminated

Ovarian Neoplasms